Etilevodopa

Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.

Etilevodopa
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.223.003
Chemical and physical data
FormulaC11H15NO4
Molar mass225.244 g·mol−1
3D model (JSmol)
  (verify)

See also

References

  1. Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E (November–December 2003). "Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study". Clinical Neuropharmacology. 26 (6): 322–6. doi:10.1097/00002826-200311000-00012. PMID 14646613. S2CID 23992241.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.